TECX

Tectonic Therapeutic Stock Analysis

AI Rating

Neutral
  • Quality2/10
  • Growth 8/10
  • Momentum 3/10
Tectonic Therapeutic sales and earnings growth
TECX Growth
Good
  • Revenue Y/Y 0.00%
  • EPS Y/Y 87.89%
  • FCF Y/Y -15.63%
Tectonic Therapeutic gross and profit margin trends
TECX Profitability
Low
  • Gross margin 0.00%
  • EPS margin 0.00%
  • ROIC 9383.70%
Tectonic Therapeutic net debt vs free cash flow
TECX Risk
Great
  • Debt / Equity 0.0
  • Debt / FCF 0.0
  • Interest coverage -907.5

Tectonic Therapeutic stock volatility is higher than the overall market. We give it a Great risk rating.

More Biotechnology stocks ↗